ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,000 | -16.0% | 3,473 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $25,000 | -13.8% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | +26.1% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $23,000 | -23.3% | 3,473 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $30,000 | +57.9% | 3,473 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $19,000 | -5.0% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $20,000 | -9.1% | 3,473 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $22,000 | +37.5% | 3,473 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $16,000 | -42.9% | 3,473 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $28,000 | -15.2% | 3,473 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $33,000 | -19.5% | 3,473 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $41,000 | -24.1% | 3,473 | 0.0% | 0.01% | -27.3% |
| Q4 2013 | $54,000 | +145.5% | 3,473 | 0.0% | 0.01% | +120.0% |
| Q3 2013 | $22,000 | -21.4% | 3,473 | 0.0% | 0.01% | -37.5% |
| Q2 2013 | $28,000 | – | 3,473 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |